Showing 1001-1010 of 3009 results for "".
Artificial Intelligence in Clinical Neurology: Opportunities, Limitations, and the Path Forward
https://practicalneurology.com/diseases-diagnoses/imaging-testing/artificial-intelligence-in-clinical-neurology-opportunities-limitations-and-the-path-forward/56386/Artificial intelligence is revolutionizing clinical neuroimaging by enhancing how neurologic conditions are diagnosed, prioritized, and managed, but its challenges must be addressed to ensure safe and fair use across diverse patient populations.Beyond the Binary: Rethinking Stroke Prevention in Atrial Fibrillation With Cerebral Amyloid Angiopathy
https://practicalneurology.com/diseases-diagnoses/stroke/beyond-the-binary-rethinking-stroke-prevention-in-atrial-fibrillation-with-cerebral-amyloid-angiopathy/54791/Neurocardiac programs can integrate imaging-informed risk stratification, comorbidity-focused research, and emerging biomarkers to guide atrial fibrillation management in people with cerebral amyloid angiopathy.Radiologic Differential Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/radiologic-differential-diagnosis-of-multiple-sclerosis/54601/This article provides an overview of the radiographic features that are shared and those that are distinct among multiple sclerosis, aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte protein antibody–associated disease.Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Genetically Targeted Therapies for Inherited Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetically-targeted-therapies-for-inherited-neuromuscular-disorders/31816/Targeted genetic therapies for neuromuscular disorders have ushered in a new era with still unresolved clinical, ethical, and economic questions to address.Anti-N-Methyl D Aspartate Receptor Encephalitis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/anti-n-methyl-d-aspartate-receptor-encephalitis/31705/Encephalitis caused by antibodies to the N-methyl-D-aspartate receptor causes symptoms of movement disorders, seizure, and psychiatric disturbances.Genetic Testing & Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetic-testing-neuromuscular-disorders/31920/The cost of genetic testing has decreased significantly, and the results are priceless.Tuberous Sclerosis Complex
https://practicalneurology.com/diseases-diagnoses/child-neurology/tuberous-sclerosis-complex/31942/Tuberous sclerosis complex represents the opportunity of targeted treatment resulting from identifying pathogenic gene variants for long-recognized syndromes.Multiple Sclerosis in the Black Population of the United States
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-black-population-of-the-united-states/31756/Black people with multiple sclerosis are affected by frequent relapses, early disability accrual, and rapid disease progression.Association of Lifestyle Factors with Cognition
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/association-of-lifestyle-factors-with-cognition/32012/Evidence supports the benefit of cognitive, social, physical, and multimodal interventions for people at different stages of cognitive and functional impairment.